Watson Pharmaceuticals, Inc. (NYSE:WPI)

CAPS Rating: 4 out of 5

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

Recs

0
Player Avatar ThickCobra (< 20) Submitted: 5/23/2008 4:25:53 PM : Outperform Start Price: $28.54 WPI Score: +155.21

Watson is expected to launch some great generics this year and increase it's production levels to meet the global demand.

Featured Broker Partners


Advertisement